Case number# PHHY2015DE027297, is an initial spontaneous report from a consumer (patient) received on 04 
Mar 2015.
This report refers to an adult female patient, born in 1991. Historical condition and concomitant medication was not 
reported. Concurrent conditions included eye disorder. 
The patient received Gilenya (fingolimod) capsule for an unknown indication since Jun 2014 at a dose of 0.5 mg, 
(route unspecified).
On an unknown date, the patient had JC virus test positive, common cold (nasopharyngitis), multiple sclerosis (MS)
symptoms worsening (multiple sclerosis relapse) and prickling sensation in her legs (paraesthesia). The patient did 
not experience other events during Gilenya therapy. Therapy with Gilenya was ongoing.
The outcome, seriousness and causality of the events were not reported. Seriousness assessment of (JC virus test
positive) was upgraded based on the NVS IME list.